BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist
about
Neuropeptide Y and EpilepsyFunctional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissuesVascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivoEffects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctionsPhysiological role of neuropeptide Y in the regulation of the ascending phase of the peristaltic reflexBlockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246Chicken neuropeptide Y receptor Y2: structural and pharmacological differences to mammalian Y2(1).The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression.The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability.Activation of NPY receptors suppresses excitatory synaptic transmission in a taste-feeding network in the lower brain stem.Ligands of the neuropeptide Y Y2 receptor.Neuropeptide Y: potential role in recurrent developmental seizures.Endogenous PYY and NPY mediate tonic Y1- and Y2-mediated absorption in human and mouse colon.Neuropeptide y gates a stress-induced, long-lasting plasticity in the sympathetic nervous system.Anticonvulsant neuropeptides as drug leads for neurological diseases.Functional reconstitution of human neuropeptide Y (NPY) Y(2) and Y(4) receptors in Sf9 insect cells.Neuropeptide Y receptor expression in human primary ovarian neoplasms.Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo.Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes.Methamphetamine-induced changes in the mice hippocampal neuropeptide Y system: implications for memory impairment.Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors.Platelet Lysate-Derived Neuropeptide y Influences Migration and Angiogenesis of Human Adipose Tissue-Derived Stromal Cells
P2860
Q24630292-A2C70206-BEB8-4648-BAD4-F32440F17C94Q24672624-8AA6BDCC-8359-4CF9-BBD1-4AF619370D1FQ28345465-A4E0D031-75F4-478D-99CE-705CB03CFDF8Q28349807-6858DD9A-2650-400D-8CDE-602038A1B9F4Q28577484-0AA91A8A-9AC0-44FB-9B9E-A26179BB3243Q28580596-AB6C6B0C-3A8B-4971-AE47-D5BF3AF7273FQ30962310-520A0CC6-DC05-4ECE-86A4-15D96C3301FDQ35045725-8BECD428-1B96-4976-AABC-8F9F5E24C5DAQ35828183-577DE40D-4CAC-4E0A-9986-7D575BAA02D3Q35859570-E18E0DC1-7CFE-4F53-B0D1-6587531C53F5Q36042848-4C5179E8-739B-499A-9046-CCC2634D2281Q36355133-B737CFD1-B1B0-4573-A02C-D1E3684616C7Q36695746-171F3B5C-80AF-44A3-869E-B63A063E213EQ36946776-C60A0C43-55D4-4578-ACDA-09F81D42610AQ37058112-D04750AB-2C31-453D-823D-3EF1F0562EA2Q37845684-6BA55709-A622-4CB7-9852-845DEDEFF5ABQ39509078-AB9F1069-148B-48B6-BFA4-AC51206115CFQ40614679-64AAAE18-FF4F-4A2A-9B37-AC2B16BAFEBFQ43051288-A27822F0-63EE-410C-900E-1F798A405D04Q43263299-3E23C893-4623-47EF-B7AD-54DCDB21534BQ43263802-21F41CB0-C296-4A24-BFCF-464FB5A4CEC4Q48338576-7784453D-427D-410E-8F81-52E0D7BE3C93Q52680710-426FD7EE-A0E7-4AC5-A062-7E21435D93C7Q58698726-04B75525-28CE-4817-AB2A-13C649017310
P2860
BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
BIIE0246, a potent and highly ...... ide Y Y(2) receptor antagonist
@en
type
label
BIIE0246, a potent and highly ...... ide Y Y(2) receptor antagonist
@en
prefLabel
BIIE0246, a potent and highly ...... ide Y Y(2) receptor antagonist
@en
P2093
P2860
P356
P1476
BIIE0246, a potent and highly ...... ide Y Y(2) receptor antagonist
@en
P2093
R Abounader
P2860
P304
P356
10.1038/SJ.BJP.0703162
P407
P50
P577
2000-03-01T00:00:00Z